NCT01369836View on ClinicalTrials.gov

Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
Healthy
Interventions
DRUG

Tafamidis meglumin

A single oral dose of 20 mg capsule

DRUG

Tafamidis meglumin

A single oral dose of 40 mg capsule.

DRUG

Placebo

A single oral dose of matched placebo.

Trial Locations (1)

91206

Pfizer Investigational Site, Glendale

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01369836 - Study Of Single Doses Of PF-06291826 (Tafamidis) In Japanese And Western Subjects | Biotech Hunter | Biotech Hunter